Biotest: Q3 FY 2015 Results (Biotest) - Nov 14, 2015 - "Tregalizumab (BT-061) – Status and Next Steps"; "ACR response Week 12"; "ACR response Week 24"; "BT-061 was biologically active but did not translate into medical benefit"
P2 data • Rheumatoid Arthritis
|